Synopsis
The world is on the threshold of a great new industrial revolution, a 1 scientific-industrial revolution. Recombinant DNA technology and hybridoma technology ("monoclonal antibodies") have already pro- vided unique investment opportunities for venture capitalists. Hence published reports of biomedical research are no longer restricted to scientific journals, but now appear regularly not only in weekly news- 2 magazines like Time and U. S. News & World Report,3 but also in the financial sections of The New York Times,4 The Wall Street Journal, S 6 8 Business Week, Fortune,7 and The Economist, as well as in such stock 9 market advisory publications as New Issues and Inc. (The Magazine for Growing Companies). 10 These publications now appear to be as impor- tant to biomedical scientists in keeping abreast of new scientific devel- opments in biotechnology as is Current Contents. (The costs of health- cost provision and of fundamental biomedical research are now also being followed by such media. ) Conversely, Wall Street financial bro- kers increasingly no longer confine their reading to economic journals but are also perusing Nature, ll Science,12 and Science N 13 for infor- ews mation on both fiscal and scientific advances in these areas. It is obvious that the information explosion in biotechnology is crossing traditional boundaries (e. g., ref. 14). This volume is the second of several that are intended to inform both the biomedical community and interested intelligent laymen of the political and economic implications of biomedical research.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Autres éditions populaires du même titre
Résultats de recherche pour Biomedical Institutions, Biomedical Funding, and Public...
Image d'archives
Biomedical Institutions, Biomedical Funding, and Public Policy
Vendeur : Lucky's Textbooks, Dallas, TX, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. N° de réf. du vendeur ABLIING23Mar2716030068775
Acheter neuf
EUR 52,65
Frais de port :
EUR 3,45
Vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Biomedical Institutions, Biomedical Funding, and Public Policy (Paperback or Softback)
Edité par
Springer 2/24/2013, 2013
ISBN 10 : 1468444506
ISBN 13 : 9781468444506
Neuf
Paperback or Softback
Vendeur : BargainBookStores, Grand Rapids, MI, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Paperback or Softback. Etat : New. Biomedical Institutions, Biomedical Funding, and Public Policy. Book. N° de réf. du vendeur BBS-9781468444506
Acheter neuf
EUR 56,45
Frais de port :
Gratuit
Vers Etats-Unis
Quantité disponible : 5 disponible(s)
Image d'archives
Biomedical Institutions, Biomedical Funding, and Public Policy
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. In. N° de réf. du vendeur ria9781468444506_new
Acheter neuf
EUR 57,54
Frais de port :
EUR 13,62
De Royaume-Uni vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Biomedical Institutions, Biomedical Funding, and Public Policy
Edité par
Springer, Springer Feb 2013, 2013
ISBN 10 : 1468444506
ISBN 13 : 9781468444506
Neuf
Taschenbuch
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The world is on the threshold of a great new industrial revolution, a 1 scientific-industrial revolution. Recombinant DNA technology and hybridoma technology ('monoclonal antibodies') have already pro vided unique investment opportunities for venture capitalists. Hence published reports of biomedical research are no longer restricted to scientific journals, but now appear regularly not only in weekly news 2 magazines like Time and U. S. News & World Report,3 but also in the financial sections of The New York Times,4 The Wall Street Journal,S 6 8 Business Week, Fortune,7 and The Economist, as well as in such stock 9 market advisory publications as New Issues and Inc. (The Magazine for Growing Companies). 10 These publications now appear to be as impor tant to biomedical scientists in keeping abreast of new scientific devel opments in biotechnology as is Current Contents. (The costs of health cost provision and of fundamental biomedical research are now also being followed by such media. ) Conversely, Wall Street financial bro kers increasingly no longer confine their reading to economic journals but are also perusing Nature,ll Science,12 and Science N 13 for infor ews mation on both fiscal and scientific advances in these areas. It is obvious that the information explosion in biotechnology is crossing traditional boundaries (e. g. , ref. 14). This volume is the second of several that are intended to inform both the biomedical community and interested intelligent laymen of the political and economic implications of biomedical research. 240 pp. Englisch. N° de réf. du vendeur 9781468444506
Acheter neuf
EUR 53,49
Frais de port :
EUR 23
De Allemagne vers Etats-Unis
Quantité disponible : 2 disponible(s)
Image d'archives
Biomedical Institutions, Biomedical Funding, and Public Policy
Vendeur : Books Puddle, New York, NY, Etats-Unis
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. pp. 240. N° de réf. du vendeur 2698253288
Acheter neuf
EUR 75,67
Frais de port :
EUR 3,45
Vers Etats-Unis
Quantité disponible : 4 disponible(s)
Image d'archives
Biomedical Institutions, Biomedical Funding, and Public Policy
Edité par
Springer-Verlag New York Inc., 2013
ISBN 10 : 1468444506
ISBN 13 : 9781468444506
Neuf
Paperback / softback
Vendeur : THE SAINT BOOKSTORE, Southport, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Paperback / softback. Etat : New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days 370. N° de réf. du vendeur C9781468444506
Acheter neuf
EUR 66,64
Frais de port :
EUR 16,43
De Royaume-Uni vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image d'archives
Biomedical Institutions, Biomedical Funding, and Public Policy
impression à la demandeVendeur : Majestic Books, Hounslow, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. Print on Demand pp. 240 49:B&W 6.14 x 9.21 in or 234 x 156 mm (Royal 8vo) Perfect Bound on White w/Gloss Lam. N° de réf. du vendeur 95192631
Acheter neuf
EUR 76,49
Frais de port :
EUR 7,39
De Royaume-Uni vers Etats-Unis
Quantité disponible : 4 disponible(s)
Image d'archives
Biomedical Institutions, Biomedical Funding, and Public Policy
impression à la demandeVendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. PRINT ON DEMAND pp. 240. N° de réf. du vendeur 1898253282
Acheter neuf
EUR 78,11
Frais de port :
EUR 9,95
De Allemagne vers Etats-Unis
Quantité disponible : 4 disponible(s)
Image fournie par le vendeur
Biomedical Institutions, Biomedical Funding, and Public Policy
Vendeur : moluna, Greven, Allemagne
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. N° de réf. du vendeur 4203877
Acheter neuf
EUR 48,37
Frais de port :
EUR 48,99
De Allemagne vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Biomedical Institutions, Biomedical Funding, and Public Policy
Edité par
Springer US, Springer New York Feb 2013, 2013
ISBN 10 : 1468444506
ISBN 13 : 9781468444506
Neuf
Taschenbuch
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The world is on the threshold of a great new industrial revolution, a 1 scientific-industrial revolution. Recombinant DNA technology and hybridoma technology ('monoclonal antibodies') have already pro vided unique investment opportunities for venture capitalists. Hence published reports of biomedical research are no longer restricted to scientific journals, but now appear regularly not only in weekly news 2 magazines like Time and U. S. News & World Report,3 but also in the financial sections of The New York Times,4 The Wall Street Journal,S 6 8 Business Week, Fortune,7 and The Economist, as well as in such stock 9 market advisory publications as New Issues and Inc. (The Magazine for Growing Companies). 10 These publications now appear to be as impor tant to biomedical scientists in keeping abreast of new scientific devel opments in biotechnology as is Current Contents. (The costs of health cost provision and of fundamental biomedical research are now also being followed by such media. ) Conversely, Wall Street financial bro kers increasingly no longer confine their reading to economic journals but are also perusing Nature,ll Science,12 and Science N 13 for infor ews mation on both fiscal and scientific advances in these areas. It is obvious that the information explosion in biotechnology is crossing traditional boundaries (e. g. , ref. 14). This volume is the second of several that are intended to inform both the biomedical community and interested intelligent laymen of the political and economic implications of biomedical research.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 240 pp. Englisch. N° de réf. du vendeur 9781468444506
Acheter neuf
EUR 53,49
Frais de port :
EUR 60
De Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)